Our editorial approach
How we collect and vet information
We gather original reporting, peer-reviewed literature, registry data, and public regulatory documents to assemble clear summaries for people researching ibogaine. When describing an evidence point we link to the primary registry or the published study that supports it, and we flag limits in sample size, design, or replicability.
For transparency about sources we cite authoritative, public resources where appropriate — for example, standards and clinical registries hosted by government or academic institutions such as the National Library of Medicine on Wikipedia's overview of information science to explain how registries are used, and educational material from university sites to explain literature review practices like those taught at Harvard University.
We also make practical distinctions between descriptive reporting (what studies show) and prescriptive guidance (what to do clinically). We do not offer treatment plans; instead we link to location pages only to show where services are described publicly.
What we cover
Ibogaine Relapse covers editorially the organization, accessibility, safety literature, legality, and practical questions about ibogaine for people researching ibogaine. Our sections are organized so a reader can move from high-level summaries to source-level documents and listings of publicly advertised treatment facilities.
When readers want to view how ibogaine is administered in operational contexts, we link directly to descriptive pages such as a guide on administration routes at how is ibogaine administered and to facility listings that are publicly available like those shown on ibogaine treatment facilities.